Measurement of heavy metals in donor blood in Canada
Fetal and neonatal exposure to lead has been assocaited with irreversible adverse effects on brain and neural development. There is no reliable threshold for the effect of lead so limiting the exposure is recommended, particularly in vulnerable groups. Some studies have reported that a blood transfusion with a high, yet clinically unapparent levels of lead can significantly increase the blood lead level of apremature infant recipient. This study will investigate where blood transfusion is a considerable source of exposure to heavy metals that requires monitoring.
We will collect a representative corss-section of Canadian donor blood sampels and measure the levels of lead along with two other toxic heavy metals, mercury and cadmium. We will also report the proportion of blood units that contain 'high' levels of these metals. Such data would allow policu makers to assess any necessity of screening blood units for heavy metals before transfusion to vulnerable groups. Further, donors' demographic factors such as age and sex will be correalted to the level of heavy metals. The possible association can be useful for the informed selection of blood units for transfusion to premature inants and or any vulnerable group; providing safer and higher quality products to the benefit of patients.
We will collect a representative corss-section of Canadian donor blood sampels and measure the levels of lead along with two other toxic heavy metals, mercury and cadmium. We will also report the proportion of blood units that contain 'high' levels of these metals. Such data would allow policu makers to assess any necessity of screening blood units for heavy metals before transfusion to vulnerable groups. Further, donors' demographic factors such as age and sex will be correalted to the level of heavy metals. The possible association can be useful for the informed selection of blood units for transfusion to premature inants and or any vulnerable group; providing safer and higher quality products to the benefit of patients.
Principal Investigator / Supervisor
DEVINE, Dana
Co-Investigator(s) / Trainee
SERRANO, Katherine
LEVIN, Elena
MURPHY, Michael
BARAKAUSKAS, Vilte
HADJESFAMDOARI, Narges
ARRIETA, Angele
RICHARDSON-SANCHEZ, Tomas
Institution
Canadian Blood Services
Program
Blood Efficiency Accelerator Program
Province
British Columbia
Total Amount Awarded
$29,971
Project Start Date
Project End Date